Italy's Chiesi buys Amryt Pharma for $1.48 billion
Italy's Chiesi Farmaceutici said it will acquire Ireland-based drugmaker Amryt Pharma, which has products and drugs in development for treating rare diseases, in a deal valued at $1.48 billion.
Business
• 09 Jan 23
